Related Experiment Video
Updated: Apr 16, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
Myxoid liposarcoma with heterologous components: dedifferentiation or metaplasia? A FISH-documented and
Noëlle Weingertner1, Agnès Neuville, Frédéric Chibon
1*Department of Pathology, University Hospital §Department of Pathology, Centre Paul Strauss, Strasbourg †Department of Pathology, Institut Bergonié, Bordeaux ‡Department of Oncology, Centre Léon Bérard, Lyon, France.
Abstract:
Heterologous differentiation in myxoid liposarcoma is a rare phenomenon. Few cases have been reported thus far, often without molecular assays, and the concept of "dedifferentiated" myxoid liposarcoma remains controversial. We describe a primary myxoid liposarcoma with chondroid and osseous components affecting the right thigh of a 27-year-old woman. We wondered whether these areas represented dedifferentiated components or simply metaplasia, and performed fluorescent in situ hybridization and array comparative genomic hybridization assays in the myxoid liposarcoma component and chondroid component. Fluorescent in situ hybridization analysis demonstrated a DDIT3 gene rearrangement in both components; array comparative genomic hybridization analysis did not detect any gain or loss of DNA regions in both components. Our results, demonstrating that both components have the same molecular alterations, suggest that heterologous components seen in some myxoid liposarcomas reflect a metaplastic phenomenon and not a real dedifferentiation phenomenon, challenging the concept of "dedifferentiated" myxoid liposarcoma.

